NIH Scientists Gripe At Ethics Rule: NO Stocks in Pharmaceutical Companies – LAT / WSJ Sat, 5 Mar 2005 A group of dissident NIH scientists represented by an 18 member executive committee, are gripping about new rules prohibiting them from accepting fees for outside activities. Conflict of interest rules apply…
Pfizer Marketing Scheme Stirs Concern_NYT / Corporate Responsibility Movement Puts PhRMA on Notice_ ICCR Mon, 7 Mar 2005 The New York Times reports that Pfizer is planning to lock up the market for heart treaments by bundling its new drug (toretrapib, which is still in experimental stage of development) to…
Bad Medicine: A Gift for Drug Makers–Malpractice Bill Shields Drugmakers Sat, 15 Jan 2005 Knowledgable critics – among them practicing physicians, health care analysts, medical journal editors, journalists, and lay citizens–have reached the conclusion that America’s for-profit health care system – which eats up 16% of the budget–has failed to…
Children’s Mental Health in the 108th Congress: The Good, The Bad, and The Ugly Wed, 15 Dec 2004 AHRP board member, Dr. Karen Effrem, provides a succinct overview of actions – the good, the bad, and the ugly–taken by the 108th Congress will have an impact on children’s health and…
Complaint to FDA: Pfizer Failed to Disclose Zoloft Suicide Risk in NYT Adverstisement Mon, 1 Nov 2004 ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP) Tel. 212-595-8974 142 West End Ave. Suite 28P Fax: 212-595-9086 New York, NY 10023 www.ahrp.org November 1, 2004 Thomas W. Abrams Director Office…
FDA Condones False Advertising about anthrax vaccine Thu, 9 Dec 2004 The FDA and the Pentagon are flagrantly violating the law and a U.S. Court ruling. On October 27, 2004, a US Court ordered the Pentagon to suspend its forced anthrax vaccination of military personnel, and the Court ordered the…
Pfizer Zoloft Warnings to Canadian Doctors Contrast to US – FDA Caves In to Pharma lobbying Thu, 10 Feb 2005 The FDA has, once again, quietly colluded with industry, compromising the safety of children’s lives to maintain drug manufacturers’ cash flow. After two FDA advisory committee hearings (Feb 2-3 and…
Clinical Trials Controversy Spotlights Flawed System – Psychiatric News Mon, 19 Jul 2004 Recent independent analyses of the published and unpublished SSRI antidepressant pediatric data submitted by manufacturers to the FDA reveal not only that a disparity exists between published and unpublished data, but it becomes increasingly clear that the…
Conflict of Interest: Profits vs Safety Congressional Investigations US Senators Pharmaceutical industry holdings, 2004: http://www.consumerwatchdog.org/resources/SenPharma.pdf Oct 12: How Did the Vioxx Debacle Happen? USA Today / Lancet Oct 4: Op Ed: Psychiatry on the Ropes–WP / Evidence-based Psychiatry Oct 3: BBC PANORAMA TONIGHT – Taken on Trust – 13 years-Medical…
Two Court Rulings Reject Pfizer-FDA Preemption Claim in Zoloft “failure to warn” cases Thu, 21 Jul 2005 In a stunning federal court order JAMES M. ROSENBAUM, US Chief District Judge in Minnesota, overturned FDA-supported pre-emption arguments in their entirety! “The FDA has no authority to declare, ipse dixit, that a…
ALLIANCE FOR HUMAN RESEARCH PROTECTION Homepage 142 West End Ave. Suite 28P New York, NY 10023 March 10, 2004 Dr. Michael Carome Chief of Compliance Office of Human Research Protections David Horowitz Director, Office of Compliance Food & Drug Administration Dept. of Health and Human Services cc: Dr. Bernard Schwetz,…
RE: Phase I Drug trials used foster children in violation of 45 CFR 46.409 and 21 CFR 50.56
The Alliance for Human Research Protection (AHRP) has reason to believe that federal regulations for the protection of children as research subjects have been seriously violated in federally funded HIV research.
We have learned that a series of Phase I and Phase II drug experiments were conducted on infants and children who were under the guardianship of the New York City Agency for Children’s Services (ACS), and living at Incarnation Children’s Center, a foster care facility under contract with ACS.
